is important since the disease can be fatal and is readily treatable once diagnosed. Twelve molecular defects have been identified in the MCAD gene; however, a single highly prevalent mutation, A985G, accounts for >90% of mutant alleles in the white population. In order to facilitate the molecular diagnosis of MCAD deficiency, oligonucleotide primers were designed to amplify the exon regions encompassing the 12 mutations enzymatically, and PCR products were then screened with a single strand conformation polymorphism (SSCP) based method. Minigels were used allowing much faster run times, and silver staining was used after gel electrophoresis to eliminate the need for radioisotopic labelling strategies. Our 4 bp deletion encompassing position 1100-1103, T1124C and A1161G), two in exon 9 (T730C and G799A), and one each in exon 6 (G447A) and exon 3 (C157T).'1-8 The A to G transition at nucleotide 985 in exon 11 of the MCAD gene accounts for > 90% of the mutant alleles characterised in white populations with MCAD deficiency while some alleles (7-8%) are still unidentified. '9 Different molecular methods are in use to detect mutations causing MCAD: modified PCR/restriction digestion, allele specific PCR (ASPCR), and allele specific oligohybridisation (ASO). Screening for the A985G mutation is generally performed by PCR using a forward primer which creates an NcoI restriction site in the mutant, but not the normal allele. Resultant PCR products are then subjected to NcoI digestion followed by electrophoresis on native agarose gels.20 This approach allows detection of the most common mutation in white populations; however, it leaves other MCAD defects undetected. Since the incidence of MCAD deficiency is relatively high in the northern European population, a rapid screening strategy is needed to establish frequency and mutation heterogeneity. Furthermore, neonatal screening is particularly useful since symptoms can be prevented by appropriate management.
Methods and results
We devised a rapid SSCP based method which identifies at least three of the 12 known mutations. SSCP analysis is an important approach for detection of base changes in PCR products, and has been recently used to distinguish DR4 alleles for determination of HLA compatibility.2122 The technique is based on the principle that under non-denaturing conditions the electrophoretic mobility of single stranded nucleic acid depends not only on size but also DNA sequence. 23 We present important modifications to the original SSCP protocol which facilitate rapid non-radioactive delineation of mutations causing disease. Our approach involves the use of minigels which also allows much faster run times, and silver nitrate staining for single stranded DNA detection which eliminates the need for radioisotopic labelling strategies. Pharmacia LKB Biotechnology (Alameda, CA) recently introduced a pre-cast gel system which uses a similar approach to mutation detection. Our protocol including PCR steps takes about four to six hours.
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